基于网络药理学及实验探讨两性霉素B导致肝、肾损伤及过敏机制

    Study on the Mechanism of Liver and Kidney Injury and Allergies Induced by Amphotericin B Based on Network Pharmacology and Experiment

    • 摘要:
      目的 通过网络药理学、细胞实验和动物实验初步探讨两性霉素B(amphotericin B,AmB)导致肝、肾损伤及过敏的机制。
      方法 对汉中市中心医院使用AmB的患者进行生化指标分析,并利用ProTox-Ⅱ进行AmB毒性预测。通过PharmMapper、CTD和SwissTargetPrediction数据库预测AmB的潜在作用靶点,利用DAVID数据库进行GO功能和KEGG通路富集分析,探索AmB可能的干预通路机制。同时,利用DisGeNET及OMIM数据库检索相关靶点,将潜在靶点和疾病靶点进行交集分析。使用STRING 11.0分析交集靶点的蛋白-蛋白相互作用(protein-protein interaction,PPI)网络,并通过Cytoscape 3.8.0软件进行网络拓扑分析。在细胞实验中,使用不同浓度的AmB处理LAD2细胞,测定其β-氨基己糖苷酶、组胺、TNF-α、MCP-1、IL-4的水平。此外,建立AmB诱导的肝、肾损伤小鼠模型,记录小鼠体质量变化,取小鼠肝脏、肾脏计算脏器指数,并进行病理学切片观察。
      结果 临床数据分析显示,使用AmB后,多个生化指标发生显著变化,表明了其对肝、肾功能有影响。此外,部分患者首次使用时出现寒战、发热等过敏样反应,表明其可能机制与Ⅰ型过敏反应不同。通过网络药理学分析,推测肾损伤和过敏反应可能与细胞炎症及肥大细胞刺激相关。体内外实验结果显示,AmB能刺激LAD2细胞脱颗粒并释放细胞因子,同时对小鼠肝、肾组织造成损伤,支持其可能引发肝、肾毒性及过敏反应的假设。
      结论 两性霉素B可以导致肝、肾损伤以及激发肥大细胞发生类过敏反应。

       

      Abstract:
      OBJECTIVE To investigate the mechanism of liver and kidney injury and allergies induced by amphotericin B(AmB) through network pharmacology, cellular experiments, and animal experiments.
      METHODS Biochemical indicator analysis was performed on patients administered AmB at Hanzhong Central Hospital. The toxicity of AmB was predicted using the ProTox-Ⅱ platform, while its potential targets were identified through the PharmMapper, CTD, and SwissTargetPrediction databases. Using the DAVID database, potential intervention mechanisms of AmB were analyzed through GO and KEGG pathway enrichment. Simultaneously, target retrieval was performed using the DisGeNET and OMIM databases, followed by an intersection analysis to identify overlapping targets between potential AmB targets and known disease-related targets. The protein-protein interaction(PPI) network of these intersecting targets was constructed using STRING 11.0 and further subjected to network topology analysis with Cytoscape 3.8.0 software. In cellular experiments, LAD2 cells treated with varying concentrations of AmB were analyzed for the levels of β-aminoglucosidase, histamine, TNF-α, MCP-1, and IL-4. Additionally, a mouse model of AmB-induced liver and kidney injury was established. Changes in mouse body weight were recorded, organ indices were calculated from liver and kidney samples, and pathological sections were observed.
      RESULTS Clinical data analysis revealed significant alterations in several biochemical markers following AmB administration, indicating its impact on liver and kidney function. Additionally, allergic reactions, including chills and fever, were observed in some patients during initial treatment, suggesting that the underlying mechanism may differ from typical typeⅠ allergic reactions. Network pharmacological analysis further hypothesized that renal injury and allergic reactions might be associated with cellular inflammation and mast cell activation. In vivo and in vitro experiments demonstrated that AmB stimulated LAD2 cells to degranulate and release cytokines, while also causing liver and kidney damage in mice, thereby supporting the hypothesis that AmB might cause liver and kidney toxicity as well as allergic reactions.
      CONCLUSION AmB can cause liver and kidney damage, as well as trigger mast cell anaphylactoid reactions.

       

    /

    返回文章
    返回